As Health Data Management wraps up 27 years of reporting on the healthcare information technology industry today, it gives me a chance to pause and reflect, and to look hopefully toward the future for the industry. Much has been accomplished. I recall an early HIMSS conference at which an exhibit featured a one terabyte database… Read More: What should lie ahead for healthcare IT in the next… »
According to scientists, Brits consume, on average, 6,000 calories on Christmas Day alone. So, in an experiment published last year in the British Medical Journal, U.K. researchers explored whether providing people with the amount of exercise required to burn off the calories in, say, a single piece of mincemeat pie (21 minutes of running) or… Read More: How long will it take to burn off these calories?:… »
23andMe CEO, Anne Wojcicki 23andMe Sales of consumer-focused DNA tests from companies like Ancestry and 23andMe are down this year. And while companies in the space aren’t offering any reasons why, experts speculate that the natural expiration of the early adopter wave and growing privacy concerns are to blame. But companies might be able to… Read More: Consumer DNA testing has hit a lull — here’s how… »
The mammoth consumer health deal Pfizer and GlaxoSmithKline struck last December is finally sealed. But things are looking markedly different at Pfizer than they did seven months ago—and that may not be a good thing, analysts say. Earlier this week, the New York drugmaker agreed to merge its off-patent drugs business, dubbed Upjohn, with Mylan,… Read More: Pfizer’s GSK consumer deal is closed, and generics go next.… »